Home >Companies >Company-results >GSK Pharma Q2 profit down 23% to ₹101 crore

New Delhi: GlaxoSmithKline (GSK)Pharmaceuticals on Monday reported 22.67% fall in standalone net profit to 100.77 crore for the quarter ended 30 September 2018.

The company had posted a net profit of 130.32 crore in the year-ago period, GSK Pharma said in a BSE filing.

Total income of the company stood at 831.13 crore for the reported quarter. It was 845.89 crore in the second quarter of 2017-18.

Shares of GSK Pharma were trading at 1,379.30 per scrip on BSE, down 3.11% from the previous close.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.

Click here to read the Mint ePaperMint is now on Telegram. Join Mint channel in your Telegram and stay updated with the latest business news.

Edit Profile
My ReadsRedeem a Gift CardLogout